Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1985-08-12
1988-05-31
Kight, John
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424 88, 424 89, 424 90, 424 93, 435243, 435244, 435245, 435253, 435822, 435883, A61K 39083, C12N 138, C12N 120
Patent
active
047480203
DESCRIPTION:
BRIEF SUMMARY
The invention relates to a vaccine against illness and diseases caused in humans or warm-blooded animals by pathogenic agents.
The problem underlying the invention is to provide for all or in any case a number of important diseases in man or warm-blooded animals produced by pathogenic agents, such as viruses, bacteria and fungi, in each case a disease-specific vaccine which effects a permanent or at least temporary immunization against said disease and/or cure of a disease which has already appeared.
The invention is based on the surprising recognition that it is possible to produce selectively forms of pathogenic agents which have lost their pathogenic properties for man or warm-blooded animals but can nevertheless have in man or animals immunization and/or healing effects.
The vaccine according to the invention is characterized in that it contains forms of the respective agents capable of living on protein not from warm-blooded animals. Advantageously these are staphylococci, in particular Staphylococcus aureus. However, other forms of bacteria can be used which are capable of living on fish protein, in particular streptococci, pneumococci, Pseudomonas aeruginosa, corynebacteria, as well as Salmonella and other pathogens. Apart from fish protein, protein can be used from crustacea, reptiles, amphibia as well as insects and worms.
The invention also relates to a method of growing forms which are non-pathogenic for man and warm-blooded animals. The method is characterized in that pathogenic agents are inoculated into a culture medium with nondenaturated protein of non-warm-blooded animals, in particular fish protein, and a colony grown under the usual cultivation conditions, this operation possibly being repeated. Presumably when this is done an adaptation takes place due to mutation and this produces the aforementioned properties of the finished vaccine.
Advantageously, at the same time mutation or selection-promoting external influences are exerted, in particular irradiation with short-wave electromagnetic radiation, cobalt radiation and/or gamma radiation. Ultraviolet radiation has proved particularly suitable. An important feature of the invention is that pathogenic microorganisms can be combatted.
The invention will be explained below with the aid of examples.
EXAMPLE 1
A Staphylococcus aureus was inoculated over a wide area in a Petri dish with the usual nutrient agar and incubated in an incubator at 37.degree. C.
After adequate growth some of the bacteria were transferred by inoculation with a platinum needle in a nutrient medium in a second Petri dish. This Petri dish was also incubated at 37.degree. C. in an incubator and in addition subjected to radiation of an UV lamp.
It was observed that the greater part of the bacteria were not capable of living on the culture medium consisting of fish protein. Only a few of the inoculated bacteria survived.
After adequate reproduction by means of a platinum needle part of the bacteria was again transferred by inoculation to a third culture medium. This was subjected after incubation to UV radiation.
This operation was repeated using new culture mediums each time.
In the present example over 150 culture transfers were necessary but this does not mean that the number could be greater or less with reduplication.
A live vaccine was made directly from the bacteria surviving on the last culture medium. Test animals (mice, rats, guinea pigs, rabbits) were inoculated with this vaccine in amounts corresponding to many times the lethal dose of the original strain. None of the inoculated animals died or showed any signs of disease. Afterwards the inoculated animals as well as uninoculated animals for check purposes were infected with a corresponding virulent strain. Even with injection amounts corresponding to many times the lethal dose for uninoculated animals the inoculated animals proved completely immune. It was possible to check the degree of immunity in the case of rabbits by precipitation according to Ouchterlony.
EXAMPLE 2
In a Petri dish with an agar cul
REFERENCES:
patent: 3625833 (1971-12-01), Schaffer
patent: 4197290 (1980-04-01), Yoshida
patent: 4285936 (1981-08-01), Pier et al.
patent: 4413057 (1983-11-01), Carlo et al.
patent: 4472378 (1984-09-01), Shuster et al.
Draper Garnette D.
Kight John
LandOfFree
Vaccine for diseases of staphylococcus aureus and methods of pre does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine for diseases of staphylococcus aureus and methods of pre, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine for diseases of staphylococcus aureus and methods of pre will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1873358